{
    "Trade/Device Name(s)": [
        "Healgen Multi-Drug Urine Test Cup",
        "Healgen Multi-Drug Urine Test Dip Card"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K151642",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142280",
        "K143187",
        "K141647",
        "K140546",
        "K150791",
        "K150096"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "JXM",
        "DIO",
        "LDJ",
        "DJG",
        "LAF",
        "DIS",
        "LCM",
        "DJR"
    ],
    "Summary Letter Date": "July 10, 2015",
    "Summary Letter Received Date": "July 14, 2015",
    "Submission Date": "June 9, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3870",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3150",
        "21 CFR 862.3620"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Benzodiazepine Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Cannabinoids Test System",
        "Methamphetamine Test System",
        "Opiate Test System",
        "Barbiturate Test System",
        "Methadone Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Dip Card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunoassay",
        "Lateral flow",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Antigen-antibody interaction",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Multi-Drug Urine Test Cup and Dip Card for qualitative detection of multiple drugs of abuse in urine using lateral flow immunochromatographic technology.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Cannabinoids, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine and Methadone in human urine at specific cutoff concentrations; preliminary test results require confirmation by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}